biote Statistics
Total Valuation
biote has a market cap or net worth of $182.24 million. The enterprise value is $279.90 million.
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 30.99 million shares outstanding. The number of shares has increased by 139.91% in one year.
| Shares Outstanding | 30.99M |
| Shares Change (YoY) | +139.91% |
| Shares Change (QoQ) | -4.47% |
| Owned by Insiders (%) | 28.89% |
| Owned by Institutions (%) | 35.78% |
| Float | 12.77M |
Valuation Ratios
The trailing PE ratio is 29.29 and the forward PE ratio is 15.89.
| PE Ratio | 29.29 |
| Forward PE | 15.89 |
| PS Ratio | 1.04 |
| Forward PS | 0.83 |
| PB Ratio | n/a |
| P/FCF Ratio | 8.71 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.13, with an EV/FCF ratio of 13.37.
| EV / Earnings | 40.73 |
| EV / Sales | 1.49 |
| EV / EBITDA | 7.13 |
| EV / EBIT | 7.34 |
| EV / FCF | 13.37 |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 0.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.08 |
| Debt / FCF | 5.85 |
| Interest Coverage | 5.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 20.54% |
| Return on Capital (ROIC) | 189.34% |
| Revenue Per Employee | $965,119 |
| Profits Per Employee | $35,423 |
| Employee Count | 194 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 3.19 |
Taxes
In the past 12 months, biote has paid $3.80 million in taxes.
| Income Tax | 3.80M |
| Effective Tax Rate | 19.74% |
Stock Price Statistics
The stock price has increased by +12.00% in the last 52 weeks. The beta is 0.95, so biote's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +12.00% |
| 50-Day Moving Average | 6.72 |
| 200-Day Moving Average | 5.89 |
| Relative Strength Index (RSI) | 43.70 |
| Average Volume (20 Days) | 166,576 |
Short Selling Information
The latest short interest is 1.18 million, so 3.79% of the outstanding shares have been sold short.
| Short Interest | 1.18M |
| Short Previous Month | 1.16M |
| Short % of Shares Out | 3.79% |
| Short % of Float | 9.21% |
| Short Ratio (days to cover) | 5.71 |
Income Statement
In the last 12 months, biote had revenue of $187.23 million and earned $6.87 million in profits. Earnings per share was $0.20.
| Revenue | 187.23M |
| Gross Profit | 130.41M |
| Operating Income | 38.11M |
| Pretax Income | 10.67M |
| Net Income | 6.87M |
| EBITDA | 39.26M |
| EBIT | 38.11M |
| Earnings Per Share (EPS) | $0.20 |
Full Income StatementBalance Sheet
The company has $26.42 million in cash and $122.39 million in debt, giving a net cash position of -$95.97 million or -$3.10 per share.
| Cash & Cash Equivalents | 26.42M |
| Total Debt | 122.39M |
| Net Cash | -95.97M |
| Net Cash Per Share | -$3.10 |
| Equity (Book Value) | -141.65M |
| Book Value Per Share | -4.62 |
| Working Capital | 15.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $24.44 million and capital expenditures -$3.50 million, giving a free cash flow of $20.93 million.
| Operating Cash Flow | 24.44M |
| Capital Expenditures | -3.50M |
| Free Cash Flow | 20.93M |
| FCF Per Share | $0.68 |
Full Cash Flow StatementMargins
Gross margin is 69.65%, with operating and profit margins of 20.35% and 3.67%.
| Gross Margin | 69.65% |
| Operating Margin | 20.35% |
| Pretax Margin | 10.27% |
| Profit Margin | 3.67% |
| EBITDA Margin | 20.97% |
| EBIT Margin | 20.35% |
| FCF Margin | 10.17% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -139.91% |
| Shareholder Yield | -139.91% |
| Earnings Yield | 3.77% |
| FCF Yield | 11.49% |
Analyst Forecast
The average price target for biote is $8.39, which is 42.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.39 |
| Price Target Difference | 42.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 17.09% |
| EPS Growth Forecast (5Y) | 104.57% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 1.92 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.92 |
| Piotroski F-Score | 6 |